Suppr超能文献

体液免疫反应在 COVID-19 中的保护作用和致病作用。

Protective and pathogenic role of humoral responses in COVID-19.

机构信息

Department of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul, 03080, Republic of Korea.

Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, 03080, Republic of Korea.

出版信息

J Microbiol. 2022 Mar;60(3):268-275. doi: 10.1007/s12275-022-2037-8. Epub 2022 Mar 2.

Abstract

Since the advent of SARS-CoV-2 in Dec. 2019, the global endeavor to identify the pathogenic mechanism of COVID-19 has been ongoing. Although humoral immunity including neutralizing activity play an important role in protection from the viral pathogen, dysregulated antibody responses may be associated with the pathogenic progression of COVID-19, especially in high-risk individuals. In addition, SARS-CoV-2 spike-specific antibodies acquired by prior infection or vaccination act as immune pressure, driving continuous population turnover by selecting for antibody-escaping mutations. Here, we review accumulating knowledge on the potential role of humoral immune responses in COVID-19, primarily focusing on their beneficial and pathogenic properties. Understanding the multifaceted regulatory mechanisms of humoral responses during SARS-CoV-2 infection can help us to develop more effective therapeutics, as well as protective measures against the ongoing pandemic.

摘要

自 2019 年 12 月 SARS-CoV-2 出现以来,全球一直在努力确定 COVID-19 的发病机制。虽然包括中和活性在内的体液免疫在防止病毒病原体方面发挥着重要作用,但失调的抗体反应可能与 COVID-19 的发病进展有关,尤其是在高危人群中。此外,先前感染或接种疫苗获得的 SARS-CoV-2 刺突特异性抗体充当免疫压力,通过选择逃逸抗体的突变来推动持续的人群更替。在这里,我们回顾了关于体液免疫反应在 COVID-19 中潜在作用的累积知识,主要关注其有益和致病特性。了解 SARS-CoV-2 感染期间体液反应的多方面调节机制有助于我们开发更有效的治疗方法以及针对持续大流行的保护措施。

相似文献

1
Protective and pathogenic role of humoral responses in COVID-19.
J Microbiol. 2022 Mar;60(3):268-275. doi: 10.1007/s12275-022-2037-8. Epub 2022 Mar 2.
2
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.
mBio. 2022 Oct 26;13(5):e0164722. doi: 10.1128/mbio.01647-22. Epub 2022 Aug 24.
3
Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects.
Cell Mol Immunol. 2022 Feb;19(2):150-157. doi: 10.1038/s41423-021-00774-w. Epub 2021 Oct 13.
5
Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19-convalescent individuals.
J Allergy Clin Immunol. 2022 Apr;149(4):1225-1241. doi: 10.1016/j.jaci.2022.01.005. Epub 2022 Jan 21.
8
Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination.
Front Immunol. 2022 May 30;13:888794. doi: 10.3389/fimmu.2022.888794. eCollection 2022.

引用本文的文献

2
Distinctive Combinations of RBD Mutations Contribute to Antibody Evasion in the Case of the SARS-CoV-2 Beta Variant.
J Microbiol Biotechnol. 2023 Dec 28;33(12):1587-1295. doi: 10.4014/jmb.2308.08020. Epub 2023 Nov 3.
3
Immune evasion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); molecular approaches.
Mol Immunol. 2023 Apr;156:10-19. doi: 10.1016/j.molimm.2022.11.020. Epub 2022 Nov 24.
4
Two years of COVID-19 pandemic: where are we now?
J Microbiol. 2022 Mar;60(3):235-237. doi: 10.1007/s12275-022-1679-x.

本文引用的文献

2
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants.
Cell Host Microbe. 2022 Jan 12;30(1):53-68.e12. doi: 10.1016/j.chom.2021.11.013. Epub 2021 Nov 27.
3
The state of complement in COVID-19.
Nat Rev Immunol. 2022 Feb;22(2):77-84. doi: 10.1038/s41577-021-00665-1. Epub 2021 Dec 15.
4
Universal Coronavirus Vaccines - An Urgent Need.
N Engl J Med. 2022 Jan 27;386(4):297-299. doi: 10.1056/NEJMp2118468. Epub 2021 Dec 15.
5
Activation of Intracellular Complement in Lungs of Patients With Severe COVID-19 Disease Decreases T-Cell Activity in the Lungs.
Front Immunol. 2021 Nov 24;12:700705. doi: 10.3389/fimmu.2021.700705. eCollection 2021.
6
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses.
Emerg Microbes Infect. 2022 Dec;11(1):147-157. doi: 10.1080/22221751.2021.2011623.
7
SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape.
Int J Mol Sci. 2021 Nov 9;22(22):12114. doi: 10.3390/ijms222212114.
8
SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation.
Front Immunol. 2021 Nov 2;12:767981. doi: 10.3389/fimmu.2021.767981. eCollection 2021.
9
Seronegative Erosive Arthritis Following SARS-CoV-2 Infection.
Rheumatol Ther. 2022 Feb;9(1):295-301. doi: 10.1007/s40744-021-00395-9. Epub 2021 Nov 16.
10
The intersection of COVID-19 and autoimmunity.
J Clin Invest. 2021 Dec 15;131(24). doi: 10.1172/JCI154886.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验